RA
BOLD

Ramius Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Ramius Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-220,784
Closed -$13.2M – 100
2019
Q4 		$13.2M Buy
+220,784
New +$8.29M 5.68% 5

Ramius Advisors's BOLD Position: Q1 2020 in Review

Ramius Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 220,784 shares — an estimated $13.2M sold.

Ramius Advisors first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $13.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Ramius Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Ramius Advisors sold 220,784 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $13.2M.
  • Ramius Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Ramius Advisors's Audentes Therapeutics, Inc position peaked at $13.2M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Ramius Advisors's 13F filing for Q1 2020, filed 14 May 2020.